Virtus Fund Advisers’s Chemours CC Stock Holding History

Virtus Fund Advisers’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-332	Closed	-$13K	–	489
2017 Q2	$13K	Hold	332	–	–	﹤0.01%	501
2017 Q1	$13K	Hold	332	–	–	﹤0.01%	508
2016 Q4	$7K	Hold	332	–	–	﹤0.01%	515
2016 Q3	$5K	Hold	332	–	–	﹤0.01%	518
2016 Q2	$3K	Hold	332	–	–	﹤0.01%	516
2016 Q1	$2K	Hold	332	–	–	﹤0.01%	518
2015 Q4	$2K	Hold	332	–	–	﹤0.01%	827
2015 Q3	$2K	Buy	+332	New	+$3.48K	﹤0.01%	822

Other funds holding CC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Virtus Fund Advisers's CC Position: Q3 2017 in Review

Virtus Fund Advisers sold out of Chemours (CC) in Q3 2017, closing a stake of 332 shares — an estimated $13K sold.

Virtus Fund Advisers first reported a position in CC in Q3 2015 and held it in 8 quarters. The position peaked at $13K in Q2 2017. 500 funds tracked by Wall St. Rank hold CC as of Q3 2017.

Virtus Fund Advisers reported no remaining Chemours position as of Q3 2017 after selling out during the quarter.
Virtus Fund Advisers sold 332 Chemours shares in Q3 2017, an estimated $13K.
Virtus Fund Advisers first reported a position in Chemours in Q3 2015 and held it in 8 quarters.
Virtus Fund Advisers's Chemours position peaked at $13K in Q2 2017.
500 funds tracked by Wall St. Rank held Chemours as of Q3 2017.

Based on Virtus Fund Advisers's 13F filing for Q3 2017, filed 13 Nov 2017.